Lviv clinical bulletin 2023, 2(42): 79-87

https://doi.org/10.25040/lkv2023.02.079

Studying Predictors of Acute Left Ventricular Failure and Criteria for the Progression of Chronic Heart Failure in Cardiac Pathologies (Literature Review: Results of Own Research)

Posted onAuthorAdminЗалишити коментар / Leave a comment

V. Denesyuk

National Pirogov Memorial Medical University, Vinnytsya

Introduction. Few works have been published in the literature on the prediction of predictors of acute and chronic heart failure.

The aim of the study. Аnalyze the achievements of cardiology in the field of studying the predictors of predicting acute left ventricular failure and the criteria for the progression of CHF with various CVD.

Materials and methods. Vikoristani 51 published an article and presented the results of public research in the field of predicting acute respiratory failure and progression of CHF in heart disease.

Results. In most patients, the term after the transferred MI is associated with an increase in end-diastolic volume and end-systolic volume, which are prognostically unfavorable signs. In these cases, the development of LV remodeling is of great importance, as well as accepting the same name as MI, stroke, and HF. Predictors of unfavorable cardiovascular diseases dynamics є: changes in EDV, ESV and left ventricular ejection fraction. It should be noted that GLS and diastolic dysfunction are important predictors of cardiovascular complications and SCD. The apparent mitral regurgitation increased the risk of death for 5 years of birth. On the basis of our research, we proved for the first time in 1991 that 4 pathogenetically related mechanisms play a leading role in the development of the initial stage of HF in SCD: central, regional pulmonary hemodynamics, microcirculation, and tissue exchange with the development of arteriolar hypoxemia, venous hyperoxia, reduction of ABB by O2 and utilization of oxygen by tissues, reduction of aerobic processes occurring in the H. A. Krebs cycle and replenishment of energy deficit due to increased glycolysis and pentose phosphate shunt (activities of succinate dehydrogenase and cytochrome oxidase).

Conclusions. Based on the given data and own results of the study, predictors of predicting acute CHF and progression are: AMI, UA severe form, stable angina pectoris 3-4 FC, cardiac aneurysm, SBP > 180 mm Hg. and < 100 mm Hg, age 70 years and older, AF, TP, VE of 3-5 gradations, “pirouette”-type VT, significant increase in EDV, ESV and decrease in LVEF. The study of predictors of acute progression and criteria for predicting CHF is of primary importance.

References

  1. Amosova KN, Bezrodniy AP, Andreev EV, Prudky IV, Kudlai VD, Zaporozhets OB et al. A similar assessment of the heart rhythm variability in patients with ailments suffered Q-myocardial infarction, with a reduced and preserved systolic function of the left duct in the dynamics of the treatment with -adrenoblockers. Heart and Judge. 2008;3(23):66-74. (Ukrainian).
  2. Amosova KM, Cherniaieva KI, Rudenko YuV, Mostbauer GV, Lazareva KP. Age and gender differences in phenotype of heart failure with preserved left ventricular ejection fraction in patients with arterial hypertension. Heart and Judge. 2018;4:53-61. (Ukrainian).
  3. Burns SA, Schmidt EA, Kipshina ES. Predictors of adverse coronary events in patients with ST-segment elevation acute coronary syndrome undergoing percutaneous coronary interventions. 2010;7:15-20. (Russian).
  4. Denesiuk VI. Diagnosis and treatment of the initial stage of heart failure in patients with coronary artery disease. Kyiv: Health; 1991. 150 p. (Russian).
  5. Denesiuk VI, Afanasyuk OI. Peculiarities of treatment of chronic heart failure in patients with coronary artery disease in combination with type II diabetes. Zaporozhye Medical Journal. 2003;6:26-27. (Ukrainian).
  6. Denesiuk VI, Denesiuk OV, Muzyka Left ventricular remodeling in patients with stable angina complicated by heart failure with reduced and preserved ejection fraction. Lviv Clinical Bulletin. 2016;2(14)-3(15):8-13. (Ukrainian).
  7. Denesiuk VI, Muzyka The content of vasodilating factors in blood serum at different degrees of systolic-diastolic dysfunction of the left ventricle in patients with stable angina complicated by heart failure. Lviv Clinical Bulletin. 2017;1(17):12-15. (Ukrainian).
  8. Denesiuk VI, Moroz VM, Denesyuk OV. Arrhythmias and heart blocks. 30-year scientific and practical experience of studying heart rhythm disorders taking into account the recommendations of evidence-based medicine. Kyiv: Center DZK; 2017. 559 р. (Ukrainian).
  9. Dotsenko MYa, Boev SS, Shekhunova IO, Gerasimenko LV. Vascular biomarkers: research methods, indicators, clinical, prognostic value and perspectives. Heart and Judgment. 2018;2:89-9 (Russian).
  10. Dynnyk OB, Havrylenko TI, Zalevsky VN. Apoptosis of cardiomyocytes, cytokines and remodeling of the myocardium against the background of the development of chronic heart failure. Medical Affair. 2005;5-6:3-9. (Russian).
  11. Karetnikova VN, Belenkova YuA, Zykov VM et al. Glycemic level as a marker of prognosis in patients with ST-segment elevation myocardial infarction. Cardiology. 2012;1:26-31. (Russian).
  12. Kinoshenko KYu, Myshchuk NE. Diastolic dysfunction of the left ventricle. Medicines of Ukraine. 2017;8(214):46-52. (Russian).
  13. Kovalenko VM, Lutay MI, Sirenko YuM, Sichov OS, editors. Heart-vessel ill. Classification, standards of diagnostics and treatment. Kyiv: Morion; 2021. 320 р. (Ukrainian).
  14. Kovalenko VM, Nesukai OG, Dolzhenko MM et al. Preventive cardiology: Implementation of international organizations in Ukraine. Kyiv: Morion; 2015. 102 р. (Ukrainian).
  15. Korol SV. Acute coronary syndrome with ST segment elevation: the predictor of in-hospital mortality. Ukrainian Therapeutical Journal. 2016;2:77-80. (Ukrainian).
  16. Malysheva OV, Sveriullina ZM, Shalaev SV. Prognostic value of various models of a certain level of coronary risk in patients with acute myocardial infarction without persistent ST segment elevations. Cardiology. 2012;4:4-9. (Russian).
  17. Oryshchyn ND, Ivanіv YuA. Predictors of ischemic mitral insufficiency in patients with left ventricular diastolic dysfunction after myocardial infarction of different localization. Ukrainian Journal of Cardiology. 2017;6:38-49. (Ukrainian).
  18. Radchenko GD, Sirenko YuM. Left ventricular hypertrophy, its regression and prognosis in patients treated in a specialized department (Results of a retrospective 5-year study). Ukrainian Journal of Cardiology. 2007;1:54-62. (Ukrainian).
  19. Saiganov AS, Khurtsilova OG, Khubulava GG et al. Influence of primary coronary balloon angioplasty on left ventricular systolic function in patients with acute heart failure and inferior Q-wave myocardial infarction. Bulletin of Surgery 2010;1:33-37. (Russian).
  20. Saigitov RT, Glezer M, Sementsov DP et al. Prognosis of hospital outcomes in acute coronary syndrome. Russian Journal of Cardiology. 2006;2(58):42-49. (Russian).
  21. Stadnik SM. Acute coronary syndrome thrombolytic therapy or coronary intervention. Emergency Medicine. 2013;7(54):115-123. (Ukrainian).
  22. Sychоv OS, Romanova EN, Hetman TV, Srybna OV. Evaluation of the efficacy and safety of the Kapikor drug in patients with heart rhythm disturbances against CAD. Arithmology. 2018;3(27):18-25. (Russian).
  23. Tashchuk VK, Polyanska OS, Gulaga OI, Gingulyak OM. Neurohumoral impact of arterial hypertension and chronic disease on hostrial myocardial infarction: pathogenetic interactions between heart remodeling and vicarious aldosterone antagonists. Arterial Hypertension. 2015;3(41):61-64. (Ukrainian).
  24. Chernyavskaya TK. ACE inhibitors in real practice: inequality of equals. Doctor. 2013;5:55-59. (Russian).
  25. Yakovlev VV, Golofeevsky VYu, Sotnikov AV. Risk factors for the development of recurrent myocardial infarction in young and middle-aged men. Therapeutic Archive. 2010;9:13-17. (Russian).
  26. Erlich AL. Scale for early assessment of the risk of death and development of myocardial infarction during hospitalization of patients with acute coronary syndrome (based on data from the RECORD register). Cardiology. 2010;10:11-16. (Russian).
  27. Abhayaratna W, Fatema K, Barnes M, Seward JB, Gersh BJ, Bailey KR et al. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons ≥65 years of age. Am J Cardiol. 2008;101(11):1626-1629.
  28. Amigoni M, Meris A, Thune JJ. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. Eur Heart J. 2007;28(3):326-333.
  29. Antman EM, Hand M, Armstrong PW. Focused update of the ACC/AHA 2004 guidelines of the management of patients with ST – elevation myocardial infarction. J Am Coll Cardial. 2008;51:210-247.
  30. Bangalore S, Messerli FH, Ou FS, Tamis-Holland J, Palazzo A, Roe MT et al. The association of admission heart rate and inhospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. Eur Heart J. 2010;31(5):552-560.
  31. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E et al. Relation between preoperative viability and postoperative improvement in LV EF and heart failure symptoms. J Nucl Med. 2001;42(1):79-86.
  32. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM et al. Left ventricular remodelling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implication. 2002;106(18):2351-2357.
  33. Denesiuk V, Muzyka N. The influence of the abclominal usage of Arginine on the factors of vasodilatation and the clinical data, complicated with cardial decompensation with reduced and preserved fracture of the ventricle that patients with stable coronary heart diseace have. Asian Journal of Science and Technology. 2017;08(04):4689-4697.
  34. Guerra F, Mancinelli L, Angelini L, Fortunati M, Rappelli A, Dessì-Fulgheri P et al. The association of left ventricular hypertensive with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients. PLoS One. 2011;6(1):e16630.
  35. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischaemic mitral regurgitation: long-term outcome and prognostic implication with quantitative Doppler assessment. Circulation. 2001;103(13):1759-1764.
  36. Hickey MS, Smith LR, Muhlbaier LH, Harrell FE, Reves JG, Hinohara T et al. Current prognosis of ischemic mitral regurgitation: implications for future management. Circulation. 1988;78(3 Pt 2):51-59.
  37. Ji H, Fang L, Yuan L, Zhang Q. Effects of exercise – based cardiac rehabilitation in patients with acute coronary syndrome: a meta – analysis. Med Sci Monit. 2019;25:5015-5027.
  38. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S et al. Glucometers in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117(8):1018-1027.
  39. Lainscak M, Cleland JGF, Lenzen MJ, Follath F, Komajda M, Swedberg K. Inrnational variation in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey. Eur J Heart Fail. 2007;9(3):292-299.
  40. Pfeffer MA, Braunwald E. Ventricular remodelling after myocardial infarction. Experimental observation and clinical implication. 1990;81(4):1169-1172.
  41. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319(2):80-85.
  42. Radford MJ, Arnold JM, Bennett SJ, Cinquegrani MP, Cleland JGF, Havranek EP et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure. A report of the American College of Cardiology/American Heart Association Talk Force on clinical data standards (Writing Committee to develop heart failure clinical data standards). J Am Coll Cardiol. 2005;46(6):1179-1207.
  43. Rogan SV, Semitko SP, Kononov AB et al. Long term results of stenting of the infarct-related artery in patients with acute myocardial infarction. J Interventional Cardiology. 2008;14:61.
  44. Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure: a quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97(20):1675-1680.
  45. Sartipy U, Albage A, Lindblom D. Improved health – related quality of life and functional status after surgical ventricular restoration. Ann Thorac Surg. 2007;83(4):1381-1387.
  46. Schömig A, Dibra A, Windecker S, Mehilli J, de Lezo JS, Kaiser C et al. A meta – analysis of 16 randomized trials of sirolimus – eluting stents versus paclitaxel – eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(14):1373-1380.
  47. Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK et al. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005;111(25):3411-3419.
  48. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Eng J Med. 2002;346(13):957-966.
  49. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104(6):636-641.
  50. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F et al. For the GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the rick of 6 – month postdis – charge death in an international registry. J Am Med Assoc. 2004;291(22):2727-2733.
  51. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end – systolic volume as the major determination of survival after myocardial infarction. Circulation. 1987;76(1):44-51.